sovaldi | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Sovaldi
US Exclusivities

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

sovaldi

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

34 API Suppliers, 9 USDMF, 9 EU WC, 3 KDMF, 7 NDC API, 25 Listed Suppliers, $ API Reference Price

34 API Suppliers
9 USDMF
9 EU WC
3 KDMF
7 NDC API
25 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

12 Intermediate Suppliers

12 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

43 FDF Dossiers, 14 FDA Orange Book, 6 Europe, 4 Canada, 2 South Africa, 17 Listed Dossiers

43 FDF Dossiers
14 FDA Orange Book
6 Europe
4 Canada
2 South Africa
17 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 14 SPI Pharma, 4 DKSH, 4 Faran Shimi Pharmaceutical, 2 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 12 BASF, 5 Corel Pharma Chem, 5 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 3 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 22 Kerry, 12 Microlex e.U, 2 Nomisma Healthcare, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 13 Roquette, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

60 Fillers, Diluents & Binders, 25 Direct Compression, 21 Coating Systems & Additives, 18 Disintegrants & Superdisintegrants, 16 Granulation, 15 Thickeners and Stabilizers, 14 Controlled & Modified Release, 13 Taste Masking, 13 Lubricants & Glidants, 12 Chewable & Orodispersible Aids, 12 Co-Processed Excipients, 9 Topical, 8 Film Formers & Plasticizers, 7 Solubilizers, 7 Parenteral, 3 Coloring Agents, 3 Emulsifying Agents, 2 API Stability Enhancers, 2 Rheology Modifiers

60 Fillers, Diluents & Binders
25 Direct Compression
21 Coating Systems & Additives
18 Disintegrants & Superdisintegrants
16 Granulation
15 Thickeners and Stabilizers
14 Controlled & Modified Release
13 Taste Masking
13 Lubricants & Glidants
12 Chewable & Orodispersible Aids
12 Co-Processed Excipients
9 Topical
8 Film Formers & Plasticizers
7 Solubilizers
7 Parenteral
3 Coloring Agents
3 Emulsifying Agents
2 API Stability Enhancers
2 Rheology Modifiers

DIGITAL CONTENT

272 News #PharmaBuzz

272 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 7 Regulatory FDF Prices, 15 Annual Reports

2 US Medicaid Prescriptions
7 Regulatory FDF Prices
15 Annual Reports

MARKET PLACE

20 APIs, 1 FDF Dossiers

20 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

358 US Patents, 28 US Exclusivities, 2 Health Canada Patents

358 US Patents
28 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ API Ref.Price (USD/KG) : 839 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

28 All

01 28GILEAD SCIENCES INC

filter Product Reset all filters

28 All

01 8LEDIPASVIR; SOFOSBUVIR

02 4SOFOSBUVIR

03 16SOFOSBUVIR; VELPATASVIR

filter Exclusivity Expiration Date Reset all filters

28 All

01 42025-04-27

02 122026-08-28

03 22027-03-19

04 22027-09-19

05 42028-06-10

06 42028-12-10

filter Exclusivity Code Reset all filters

28 All

01 4M-277

02 4ODE*

03 2ODE-258

04 2ODE-262

05 2ODE-263

06 2ODE-264

07 2ODE-293

08 4ODE-376

09 6PED

Product Main Page

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE*

Exclusivity Expiration Date

2026-08-28

Application Number

204671

Product Number

2

Exclusivity Details

01

GILEAD SCIENCES INC

Peptide-Based Therapeutics Summit

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Peptide-Based Therapeutics Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE*

Exclusivity Expiration Date : 2026-08-28

Application Number : 204671

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE*

Exclusivity Expiration Date

2026-08-28

Application Number

204671

Product Number

1

Exclusivity Details

02

GILEAD SCIENCES INC

Peptide-Based Therapeutics Summit

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Peptide-Based Therapeutics Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE*

Exclusivity Expiration Date : 2026-08-28

Application Number : 204671

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

LEDIPASVIR; SOFOSBUVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE*

Exclusivity Expiration Date

2026-08-28

Application Number

205834

Product Number

2

Exclusivity Details

03

GILEAD SCIENCES INC

LEDIPASVIR; SOFOSBUVIR

Peptide-Based Therapeutics Summit

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Peptide-Based Therapeutics Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

LEDIPASVIR; SOFOSBUVIR

Exclusivity Code : ODE*

Exclusivity Expiration Date : 2026-08-28

Application Number : 205834

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-277

Exclusivity Expiration Date

2025-04-27

Application Number

208341

Product Number

2

Exclusivity Details

04

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Peptide-Based Therapeutics Summit

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Peptide-Based Therapeutics Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : M-277

Exclusivity Expiration Date : 2025-04-27

Application Number : 208341

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

LEDIPASVIR; SOFOSBUVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE*

Exclusivity Expiration Date

2026-08-28

Application Number

205834

Product Number

1

Exclusivity Details

05

GILEAD SCIENCES INC

LEDIPASVIR; SOFOSBUVIR

Peptide-Based Therapeutics Summit

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Peptide-Based Therapeutics Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

LEDIPASVIR; SOFOSBUVIR

Exclusivity Code : ODE*

Exclusivity Expiration Date : 2026-08-28

Application Number : 205834

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-376

Exclusivity Expiration Date

2028-06-10

Application Number

208341

Product Number

2

Exclusivity Details

06

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Peptide-Based Therapeutics Summit

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Peptide-Based Therapeutics Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : ODE-376

Exclusivity Expiration Date : 2028-06-10

Application Number : 208341

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-293

Exclusivity Expiration Date

2027-03-19

Application Number

208341

Product Number

2

Exclusivity Details

07

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Peptide-Based Therapeutics Summit

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Peptide-Based Therapeutics Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : ODE-293

Exclusivity Expiration Date : 2027-03-19

Application Number : 208341

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-277

Exclusivity Expiration Date

2025-04-27

Application Number

208341

Product Number

1

Exclusivity Details

08

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Peptide-Based Therapeutics Summit

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Peptide-Based Therapeutics Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : M-277

Exclusivity Expiration Date : 2025-04-27

Application Number : 208341

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-376

Exclusivity Expiration Date

2028-06-10

Application Number

208341

Product Number

1

Exclusivity Details

09

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Peptide-Based Therapeutics Summit

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Peptide-Based Therapeutics Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : ODE-376

Exclusivity Expiration Date : 2028-06-10

Application Number : 208341

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-293

Exclusivity Expiration Date

2027-03-19

Application Number

208341

Product Number

1

Exclusivity Details

10

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Peptide-Based Therapeutics Summit

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Peptide-Based Therapeutics Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : ODE-293

Exclusivity Expiration Date : 2027-03-19

Application Number : 208341

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!